文献速递糖尿病

夜间褪黑素分泌与2型糖尿病风险:一项前瞻性队列研究

Nocturnal melatonin secretion and risk of type 2 diabetes: a prospective cohort study.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该研究基于瑞典Malmö后代研究队列,纳入4491名无2型糖尿病成人,随访中位6.5年,用晨尿6-硫酸氧褪黑素与肌酐比值评估夜间褪黑素分泌。结果发现最低五分位者2型糖尿病风险显著高于其他五分位(多变量校正HR 1.51,95%CI 1.09-2.09),提示低夜间褪黑素分泌与2型糖尿病发病独立相关。

要点

  • 低夜间褪黑素分泌与2型糖尿病发病风险升高独立相关。
  • 该关联在进一步校正睡眠时长和睡眠紊乱后仍显著。
  • 研究仅依赖单次晨尿样本评估褪黑素分泌,需进一步验证。

核心结论

  • 低夜间褪黑素分泌与成人2型糖尿病发病率升高独立相关。

研究设计与样本

  • 前瞻性队列研究,随访2013至2023年(中位6.5年),纳入4491名18-75岁无2型糖尿病且未补充褪黑素的成人,来自瑞典南部Malmö后代研究。
  • 夜间褪黑素分泌以晨尿6-硫酸氧褪黑素与肌酐比值(aMT6s/Cr)评估,并按性别特异性五分位分组。
  • 新发2型糖尿病通过国家和区域健康登记确定。

主要发现

  • 随访期间171名参与者发生2型糖尿病。
  • aMT6s/Cr最低五分位者2型糖尿病风险高于第2至第5五分位者(多变量校正HR 1.51,95%CI 1.09-2.09)。
  • 进一步校正睡眠时长和睡眠紊乱后关联仍显著(HR 1.54,95%CI 1.11-2.13)。
  • 按性别标准化对数aMT6s/Cr每升高1个标准差,2型糖尿病风险HR为0.84(95%CI 0.73-0.97)。
  • 关联在性别、年龄和BMI亚组中一致。

临床怎么用

  • 夜间褪黑素分泌水平可能作为2型糖尿病风险分层的参考指标。
  • 对于低夜间褪黑素分泌者,可关注其代谢健康并加强糖尿病预防。

局限性

  • 仅依赖单次晨尿样本估计褪黑素分泌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Melatonin regulates circadian rhythms and influences glucose metabolism. Altered melatonin secretion may contribute to the pathogenesis of type 2 diabetes (T2D), but prospective population-based evidence is scarce. OBJECTIVE: To examine whether low nocturnal melatonin secretion is associated with an increased risk of incident T2D in adults. METHODS: This prospective cohort study, with follow-up from 2013 to 2023 (median 6.5 years), included a total of 4491 adults (52% women, aged 18-75 years) without T2D and melatonin supplementation at baseline, from the Malmö Offspring Study, a population-based cohort in southern Sweden. Incident T2D was identified via national and regional health registers. Nocturnal melatonin secretion was assessed as the urinary 6-sulfatoxymelatonin-to-creatinine ratio (aMT6s/Cr) from first-morning urine samples, categorized into sex-specific quintiles. RESULTS: During follow-up, 171 participants developed T2D. Participants in the lowest quintile of aMT6s/Cr had a higher T2D risk than those in quintiles 2 to 5 (multivariable adjusted hazard ratio [HR] 1.51, 95% CI 1.09-2.09). The association remained significant after additional adjustment for sleep duration and disruption (HR 1.54, 95% CI 1.11-2.13). When analyzing T2D development per 1-SD higher sex-standardized log aMT6s/Cr, the HR was 0.84 (95% CI 0.73-0.97). Associations were consistent across sex, age, and BMI subgroups. CONCLUSION: Low nocturnal melatonin secretion was independently associated with a higher incidence of T2D in adults. A key limitation is the reliance on a single morning urine sample to estimate melatonin secretion. The findings support circadian regulation as a determinant of metabolic health and warrant further investigation of melatonin pathways in diabetes prevention.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sojakka Smith E, Franzén A, Pihlsgård M, et al. Nocturnal melatonin secretion and risk of type 2 diabetes: a prospective cohort study. J Clin Endocrinol Metab. 2026. PMID: 41389002. doi:10.1210/clinem/dgaf667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。